Women's Health Policy

ABORTION IN THE U.S.

Variability in Rebimbursement Rates for State-funded Abortion Services for Medicaid Enrollees: A 2026 Update

This analysis reveals that while more states have begun using their own funds to cover abortion services for Medicaid enrollees since the U.S. Supreme Court’s Dobbs decision, only a handful have significantly increased reimbursement rates for providers, potentially undermining access to care for low-income patients. After examining physician fee schedules for abortions provided to Medicaid enrollees since 2024, KFF finds that reimbursement rates vary dramatically across states, and that most states don't substantially increase payment rates for later-pregnancy procedures, despite their higher costs and complexity.

CONTRACEPTIve care IN THE U.S.

An Update on Medicaid, Title X and Planned Parenthood

This brief provides an update on Planned Parenthood clinic closures and participation in the Title X program amid substantial policy changes resulting in funding reductions. These changes include the One Big Beautiful Bill Act and the withholding of federal Title X funding to Planned Parenthood clinics.

SELECTED RESOURCES

Over-the-Counter Oral Contraceptive Pills

In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.

featured

A promotional image for the the KFF Health Policy 101 Issues in Women’s Health chapter

Health Policy Issues in Women’s Health

Examine the core health coverage and access issues —shaped by federal and state policies—that affect women’s health today, including health coverage and costs, reproductive health services, maternal health, mental health, and intimate partner violence.

State Profiles for Women’s Health

Explore the latest national and state-specific data and policies on women’s health. Topics include health status, insurance and Medicaid coverage, use of preventive services, sexual health, maternal and infant health, and abortion policies. Many indicators provide state-level information for women of different racial and ethnic groups.

The essentials
  • Women’s Health Insurance Coverage

    This factsheet reviews major sources of coverage for women residing in the U.S., discusses the ACA's impact on coverage, and the coverage challenges that many women continue to face.
  • Medicaid Coverage for Women

    This data note presents key data points describing the current state of the Medicaid program as it affects women, including eligibility, reproductive health, chronic conditions, and more.
  • Dobbs: What are the Implications for Racial Disparities?

    This analysis examines the implications of the Dobbs decision and state restrictions on abortion coverage for racial disparities in access to care and health outcomes.
  • State Health Facts: Women's Health Indicators

    Information on women’s health status, utilization of services, health insurance coverage, family planning and childbirth, and abortion statistics and policies.
  • Key Facts on Abortion in the United States

    This report answers some key questions about abortion in the United States and presents data collected before the overturn of Roe v. Wade.

Stay informed.

Stay informed.

Filter

861 - 870 of 876 Results

  • What is the future of contraceptive care in a post-Roe world?

    Event Date:
    Event

    On December 13th, KFF held a web event highlighting key findings from KFF’s 2022 Women’s Health Survey on women’s contraceptive access, experiences, and preferences. After the presentation of the survey findings, leaders in sexual and reproductive health care explored the challenges and opportunities in contraceptive care access in a rapidly changing policy and clinical context.

  • Year in Review: 10 Health Policy Issues for 2023

    Fact Sheet

    This fact sheet offers a look back at 10 issues that KFF tracked closely during 2023 in its polling, policy analysis and journalism, including summaries of major findings and news stories.

  • IVF as an Election and Policy Issue 

    Quick Insights

    While public support for IVF is high, Congress has been unable to agree even on the right to get IVF services. Agreement on coverage and funding seem even more out of reach

  • KFF Health Tracking Poll March 2024: Abortion in the 2024 Election and Beyond

    Feature

    This poll finds 1 in 8 voters say abortion is the most important issue to their vote. They are younger, lean Democratic, and generally want abortion to be legal in all or most cases. The poll also gauges the public's views on abortion-related policies, including a national 16-week abortion ban and allowing abortion for pregnancy-related emergencies.

  • 1 in 8 Voters Say Abortion Is Most Important to Their Vote: They Lean Democratic, Support Biden, and Want Abortion to Be Legal

    News Release

    About 1 in 8 voters (12%) now say that abortion is the most important issue for their vote in the 2024 elections, highlighting how the issue could motivate groups of voters who largely say abortion should be legal in all or most cases, a new KFF Health Tracking Poll finds. The issue resonates with certain key groups of women voters. More than 1 in 4 Black women voters (28%), and about a fifth of Democratic…

  • KFF Examines the Hyde Amendment and its Impact in States Without Abortion Bans

    News Release

    KFF takes a new look at the continued impact of the Hyde Amendment, the federal ban on payment for abortion services, in the wake of the Supreme Court’s Dobbs decision. At a moment when all eyes are on states that have banned abortion, the Hyde Amendment remains a barrier to abortion care for people with low incomes in states where abortion is legal but the state restricts Medicaid coverage to the narrow exceptions allowed under…

  • The Supreme Court, Medication Abortion, and the FDA: What’s at Stake?

    News Release

    In advance of oral arguments about access to medication abortion before the Supreme Court on March 26, KFF examines how a Court ruling for the plaintiffs would limit access to mifepristone blocking its use in telehealth and distribution through pharmacies, including in states where abortion is legal and protected. In addition, it could potentially weaken the role of the Food and Drug Administration (FDA) in drug reviews—something the Court has never done before. As part…

  • One in Five Women of Reproductive Age in States with Abortion Bans Say They or Someone They Know Has Had Difficulty Accessing an Abortion Since Dobbs

    News Release

    According to new KFF polling, in states with abortion bans, one in five (21%) women of reproductive age (18 to 49) and one in seven (14%) of all women say either they or someone they know has had difficulty accessing an abortion since the Supreme Court overturned Roe v. Wade. The survey finds that among all women, including in states where abortion remains broadly legal or limited by gestational period, 8% say they or someone…